Policy · solution · 4+7 purchase with quantity leads to "Butterfly Effect" medical insurance negotiation bargain

Original: Linan In this month, volume purchasing is still the focus of the industry The state has made great efforts to promote a new round of centralized purchase At the time when the State Council issued several measures to deepen medical reform through centralized purchase, the new round of centralized purchase of 35 varieties of drugs was called for volume reporting With the state encouraging local governments to explore the centralized procurement of specific varieties, Jiangxi is currently promoting the procurement of non evaluated drugs, while Hebei is also launching the centralized procurement of "two diseases" drugs The "Butterfly Effect" of 4 + 7 appears It is expected that more varieties will be added to the list of centralized mining under the combination of national and local centralized mining In addition to drugs, the first Trans provincial alliance of Beijing, Tianjin and Hebei is also promoting the negotiation of consumables in an orderly manner In addition, the national health insurance negotiation was also settled this month, which is the largest health insurance catalog negotiation since the establishment of the health insurance system in China The "soul bargaining" of health insurance experts has attracted wide attention both inside and outside the industry On the other hand, the drug regulatory bureau is also constantly optimizing the approval process, such as encouraging overseas innovative drugs to apply for review and listing in China first, and stimulating domestic drugs at the same time Enterprises develop more new drugs based on clinical needs; NDRC issues documents to limit and eliminate a number of backward pharmaceutical production capacity.. Various policies are conducive to pharmaceutical innovation, and the pace of integration and upgrading of the pharmaceutical industry is accelerated.